Education
About Us
Working with TipRanks
Follow Us
Sylvie Gregoire Insider Profile
4 Followers
Sylvie Gregoire, Director at Revvity, holds 1.50M shares in CervoMed (Ticker: CRVO), holds 20.48K shares in Revvity (Ticker: RVTY), holds 5.08K shares in Cubist Pharma (Ticker: CBST). Most recently, Sylvie Gregoire Bought ― shares of CervoMed on Nov 19, 2025 for an estimated value of $182.74K.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+1.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Sylvie Gregoire holds in companies
Most Profitable Insider Trade
The most profitable trade made by Sylvie Gregoire
Sylvie Gregoire's Trading History
Revvity
May 17, 2023
Director
Uninformative Buy
―
$2.14M
CervoMed
Nov 19, 2025
Director, Ten Percent Owner
Informative Buy
182.74K
$14.88M
Cubist Pharma
Jun 14, 2010
―
Uninformative Buy
―
―
List of latest transactions for each holding click on a transaction to see Sylvie Gregoire's performance on stock
You May Also Like
Sylvie Gregoire insider profile FAQ
What is the percentage of profitable transactions made by Sylvie Gregoire?
The percentage of profitable transactions made by Sylvie Gregoire is 50%.
What is the average return per transaction made by Sylvie Gregoire?
The average return per transaction made by Sylvie Gregoire is 1.10%.
What stocks does Sylvie Gregoire hold?
Sylvie Gregoire holds: RVTY, CRVO, CBST stocks.
What was Sylvie Gregoire’s latest transaction?
Sylvie Gregoire latest transaction was an Informative Buy of $182.74K.
What was Sylvie Gregoire's most profitable transaction?
Sylvie Gregoire’s most profitable transaction was an Informative Buy of CRVO stock on November 13, 2025. The return on the trade was 5.90%.
What is Sylvie Gregoire's role in Revvity?
Sylvie Gregoire's role in Revvity is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.